Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 66, Issue 4, 1998, Pages 255-261

  Thierry Palmer, Myrtle ^a   Carlyle, Kemia S ^a   Williams, Monet D ^a   Tewolde, Teclemicael ^a   Caines McKenzie, Sheres ^a   Bayorh, Mohamed A ^a   Emmett, Nerimiah L ^a   Harris Hooker, Sandra A ^a   Sanford, Gary L ^a   Williams, Evan F ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HYPERTENSION; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; SALT INTAKE; SODIUM RETENTION; VITAMIN BLOOD LEVEL;

ANIMALS; BLOOD PRESSURE; CALCIFEDIOL; DIET, SODIUM-RESTRICTED; DISEASE SUSCEPTIBILITY; HYPERTENSION; MALE; RATS; RATS, INBRED STRAINS; REGRESSION ANALYSIS; SODIUM, DIETARY; SYSTOLE;

ANIMALIA;

EID: 0031694645     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00037-5     Document Type: Article

References (42)

1. Bukoski R. D., Ishibashi K. and Bian K., Vascular actions of the calcium-regulating hormones. Seminars in Nephrology 15 (1995) 536-549.
2. Mac Carthy E. P., Yamashita W., Hsu A. and Ooi B. S., 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13 (1989) 954-959.
3. 3 enhances resistance artery contractile properties. Hypertension 16 (1990) 523-531.
4. 3 attenuates the loss of resistance artery contractile function associated with incubation in culture media. Biochemical and Biophysical Research Communications 174 (1991) 11-17.
5. 3 modulates growth of vascular smooth muscle cells. Journal of Clinical Investigation 87 (1991) 1889-1895.
6. 3. American Journal of Hypertension 6 (1993) 388-396.
7. 3. Endocrine Reviews 10 (1989) 351-365.
8. 3 in the rat heart. Endocrinology 134 (1994) 899-905.
9. 3 receptor protein in human heart. Cell Biology International 20 (1996) 621-624.
10. Resnick L. M., Calciotropic hormones in salt-sensitive essential hypertension, 1,25-dihydroxyvitamin D and parathyroid hypertensive factor. Journal of Hypertension 12 (suppl 1) (1994) S3-S9.
11. Fujita T., Henry W. L., Barter F. C., Lake C. R. and Delea C. S., Factors influencing blood pressure in salt-sensitive patients with hypertension. American Journal of Medicine 69 (1980) 334-344.
12. Resnick L. M., Müller F. B. and Laragh J. H., Calcium-regulating hormones in essential hypertension. Annals of Internal Medicine 105 (1986) 649-654.
13. Hughes G. S. Jr., Oexmann M. J., Margolius H. S., Epstein S. and Bell N. H., Normal vitamin D and mineral metabolism in essential hypertension. American Journal of the Medical Sciences 296 (1988) 252-259.
14. Imaoka M., Morimoto S., Kitano S., Fukuo F. and Ogihara T., Calcium metabolism in elderly hypertensive patients: Possible participation of exaggerated sodium, calcium and phosphate excretion. Clinical and Experimental Pharmacology and Physiology 18 (1991) 631-641.
15. Dahl L. K., Salt and hypertension. American Journal of Clinical Nutrition 25 (1972) 231-244.
16. Dahl L. K. and Schackow E., Effects of chronic excess salt ingestion: Experimental hypertension in the rat. Canadian Medical Association Journal 90 (1964) 155-160.
17. Dahl L. K., Heine M. and Thompson K., Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circulation Research 34 (1974) 94-101.
18. Tobian L., Lange J., Azar S., Iwai J., Koop D., Coffee K. and Johnson M. A., Reduction of natriuretic capacity and renin release in isolated blood perfused kidneys of Dahl-hypertension-prone rats. Circulation Research 43 (1978) 92-98.
19. Kotchen T. A., Ott C. E., Whitescarver S. A., Resnick L. M., Gertner J. M. and Blehschmidt N. G., Calcium and calcium regulating hormones in the "prehypertensive" Dahl salt sensitive rat (calcium and salt sensitive hypertension). American Journal of Hypertension 2 (1989) 749-753.
20. Reinhardt T. A. and Hollis B. W., 1,25-dihydroxyvitamin D microassay employing radioreceptor techniques. Methods in Enzymology 123 (1986) 176-185.
21. Kurtz T. W., Portale A. A. and Morris R. C. Jr., Evidence for a difference in vitamin D metabolism between spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 8 (1986) 1015-1020.
22. Thierry-Palmer M., Tewolde T., Wang M., Carlyle K. S., Bayorh M. A., Emmett N. L., Forte C. and Williams E. F., Accelerated metabolism of 25-hydroxyvitamin D in salt-induced hypertension. FASEB Journal 12 (1998) A90 (abstract).
23. Norman, A. W., Vitamin D. In Present Knowledge in Nutrition, eds E. E. Ziegler and L. J. Filer, Jr. ILSI Press, Washington, DC, 1996, pp. 120-122.
24. Shingu T., Matsuura H., Kusaka M., Inoue I., Yuasa A., Shingu T., Ishida T. and Kajiyama G., Significance of intracellular free calcium and magnesium and calcium-regulating hormones with sodium chloride loading in patients with essential hypertension. Journal of Hypertension 9 (1991) 1021-1028.
25. Baran D. T. and Milne M., 1,25-Dihydroxyvitamin D increases hepatocyte cytosolic calcium levels. A potential regulator of vitamin D-25-hydroxylase. Journal of Clinical Investigation 77 (1986) 1622-1626.
26. Gibaldi M., Ethnic differences in the assessment and treatment of disease. Pharmacotherapy 13 (1993) 170-176.
27. Burt V. L., Whelton P., Roccella E. J., Brown C., Cutler J. A., Higgins M., Horan M. J. and Labarthe D., Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 (1995) 305-313.
28. Falkner B. and Kushner H., Effect of chronic sodium loading on cardiovascular response in young blacks and whites. Hypertension 15 (1990) 36-43.
29. Weinberger M. H., Miller J. Z., Luft F. C., Grim C. E. and Fineberg N., Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8 (suppl II) (1986) 127-143.
30. Bell N. H., Greene A., Epstein S., Oexmann M. J., Shaw S. and Shary J., Evidence for alteration of the vitamin D-endocrine system in blacks. Journal of Clinical Investigation 76 (1985) 470-473.
31. Kleerekoper M., Nelson D. A., Peterson E. L., Flynn M. J., Pawluszka A. S., Jacobsen G. and Wilson P., Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55-75) postmenopausal white and black women. Journal of Bone and Mineral Research 9 (1994) 1267-1276.
32. Parisien M., Morgan D., Shen V., Schnitzer X., Liang X., Luckey M., Meier D., Nieves J., Cosman F., Lindsay R. and Dempster D. W., Bone histomorphometry reveals subtle differences between black and white premenopausal women. Journal of Bone and Mineral Research, 10 (suppl 1) (1995) S444(abstract).
33. Brickman A. S., Nyby M. D., Griffiths R. F., von Hungen K. and Tuck M. L., Racial differences in platelet cytosolic calcium and calcitropic hormones in normotensive subjects. American Journal of Hypertension 6 (1993) 46-51.
34. Meier D. E., Luckey M. M., Wallenstein S., Clemens T. L., Orwoll E. S. and Waslien C. I., Calcium, vitamin D, parathyroid hormone status in young white and black women: Association with racial differences in bone mass. Journal of Clinical Endocrinology and Metabolism 12 (1991) 703-710.
35. Hollis B. W. and Pittard W. B. III, Evaluation of the total feto-maternal vitamin D-relationship at term: Evidence for racial differences. Journal of Clinical Endocrinology and Metabolism 59 (1984) 652-657.
36. Looker A. C., Gunter E. W. and Calvo M. S., Low vitamin D status appears common in both young and old blacks. Journal of Bone and Mineral Research, 11 (suppl 1) (1996) S317 (abstract).
37. Kokot F., Pietrek J., Srokowska W., Wartenberg J., Kuska M., Jedrychowska M., Duda G., Zielinska K., Wartenberg Z. and Kuzmiak M., 25-Hydroxyvitamin D in patients with essential hypertension. Clinical Nephrology 16 (1981) 188-192.
38. 3 levels: A community-based study. International Journal of Epidemiology 19 (1990) 559-563.
39. Kokot F., Schmidt-Gayk H., Wiecek A., Mleczko Z. and Bracel B., Influence of ultraviolet irradiation on plasma vitamin D and calcitonin levels in humans. Kidney International 36 (suppl 27) (1989) S143-S146.
40. Brickman A. S., Nyby M. D., von Hungen K., Eggena P. and Tuck M. L., Calcitropic hormones, platelet calcium, and blood pressure in essential hypertension. Hypertension 16 (1990) 515-522.
41. Orwoll E. S. and Oviatt S., Relationship of mineral metabolism and long-term calcium and cholecalciferol supplementation to blood pressure in normotensive men. American Journal of Clinical Nutrition 52 (1990) 717-721.
42. Morimoto S., Imaoka M., Kitano S., Imanaka S., Fukuo K., Miyashita Y., Koh E. and Ogihara T., Exaggerated natri-calciuresis and increased circulating levels of parathyroid hormone and 1,25-dihydroxyvitamin D in patients with senile hypertension. Contributions to Nephrology 90 (1991) 94-98.